Vaneck Biotech Etf Piotroski F Score

BBH Etf  USD 166.33  0.68  0.41%   
This module uses fundamental data of VanEck Biotech to approximate its Piotroski F score. VanEck Biotech F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of VanEck Biotech ETF. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about VanEck Biotech financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out VanEck Biotech Altman Z Score, VanEck Biotech Correlation, Portfolio Optimization, as well as analyze VanEck Biotech Alpha and Beta and VanEck Biotech Hype Analysis.
  
At this time, it appears that VanEck Biotech's Piotroski F Score is Inapplicable. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
0.0
Piotroski F Score - Inapplicable
Current Return On Assets

N/A

Focus
Change in Return on Assets

N/A

Focus
Cash Flow Return on Assets

N/A

Focus
Current Quality of Earnings (accrual)

N/A

Focus
Asset Turnover Growth

N/A

Focus
Current Ratio Change

N/A

Focus
Long Term Debt Over Assets Change

N/A

Focus
Change In Outstending Shares

N/A

Focus
Change in Gross Margin

N/A

Focus

VanEck Biotech Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to VanEck Biotech is to make sure VanEck is not a subject of accounting manipulations and runs a healthy internal audit department. So, if VanEck Biotech's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if VanEck Biotech's financial numbers are properly reported.

About VanEck Biotech Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

About VanEck Biotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze VanEck Biotech ETF's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VanEck Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VanEck Biotech ETF based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Biotech is traded on NASDAQ Exchange in the United States.

Pair Trading with VanEck Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if VanEck Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VanEck Biotech will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to VanEck Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace VanEck Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back VanEck Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling VanEck Biotech ETF to buy it.
The correlation of VanEck Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VanEck Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VanEck Biotech ETF moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for VanEck Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:
Check out VanEck Biotech Altman Z Score, VanEck Biotech Correlation, Portfolio Optimization, as well as analyze VanEck Biotech Alpha and Beta and VanEck Biotech Hype Analysis.
Note that the VanEck Biotech ETF information on this page should be used as a complementary analysis to other VanEck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for VanEck Etf analysis

When running VanEck Biotech's price analysis, check to measure VanEck Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VanEck Biotech is operating at the current time. Most of VanEck Biotech's value examination focuses on studying past and present price action to predict the probability of VanEck Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VanEck Biotech's price. Additionally, you may evaluate how the addition of VanEck Biotech to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.